A prospective double-blinded, randomized, placebo-controlled trial on the use of letrozole pretreatment with misoprostol for second-trimester medical abortion
Authors:
- Vivian Chi Yan LeeVLVivian Chi Yan Lee
- Oi Shan TangOTOi Shan Tang
- Ernest Hung Yu NgENErnest Hung Yu Ng
- William Shu Biu YeungWYWilliam Shu Biu Yeung
- Pak Chung HoPHPak Chung Ho
- 31 December 2011
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 84 (6) , 628-633
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Mifepristone and second trimester pregnancy termination for fetal abnormality in Western Australia: Worth the effortAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2010
- A randomized trial to compare two dosing intervals of misoprostol following mifepristone administration in second trimester medical abortionHuman Reproduction, 2008
- Mifepristone in Second-Trimester Medical AbortionObstetrics & Gynecology, 2007
- Outcomes of second-trimester pregnancy terminations with misoprostol: Comparing 2 regimensAmerican Journal of Obstetrics and Gynecology, 2005
- Tumor response and estrogen suppression in breast cancer patients treated with aromatase inhibitorsAnnals of Oncology, 2000
- A comparison of two regimens of intravaginal misoprostol for termination of second trimester pregnancy: a randomized comparative trialHuman Reproduction, 2000
- Nonsurgical mid‐trimester termination of pregnancy: a review of 500 consecutive casesBJOG: An International Journal of Obstetrics & Gynaecology, 1999
- Letrozole, a new oral non-steroidal aromastase inhibitor in treating postmenopausal patients with advanced breast cancer. A pilot studyAnnals of Oncology, 1996
- ARIMIDEX™: A new oral, once-a-day aromatase inhibitorThe Journal of Steroid Biochemistry and Molecular Biology, 1995
- Progesterone receptor blockageContraception, 1985